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CASE REPORT
Case Report
A 49-year-old man, who was neither a hepatitis B
nor hepatitis C virus carrier, received an annual
health checkup for the third time in November
2006. His plain chest film showed only mild
widening of the mediastinum. Liver function tests
and α-fetoprotein values were all within normal
limits. He had never complained of any abdomi-
nal discomfort in recent years. In the past 2 years,
abdominal ultrasound during his annual health
checkup was negative for hepatic abnormalities.
In the present checkup, a hyperechoic nodule
with a hypoechoic halo in the liver, which mea-
sured 3.0 cm in diameter, was found incidentally
by abdominal ultrasound. Abdominal magnetic
resonance imaging (MRI) was then arranged,
which showed a necrotic hepatic tumor that mea-
sured about 3.3 cm in diameter in segment VIII of
the liver, with extension to the gallbladder fossa.
Metastasis was first considered because of the MRI
appearance of the hepatic tumor; however, other
possibilities including mycobacterial infection
and abscess could not be excluded. Echo-guided
fine-needle biopsy of the hepatic tumor was then
performed. The original pathology report was
undifferentiated carcinoma, while the differential
diagnosis included hepatocellular carcinoma, chol-
angiocarcinoma and metastatic adenocarcinoma.
As a result of inconclusive ultrasound, MRI and
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Thymic carcinoma is a rare anterior mediastinal malignancy. Most patients present initially with chest
pain, cough or dyspnea. Asymptomatic patients account for less than one third of the total cases. Thymic
carcinoma is aggressive and tends to metastasize to the lymph nodes, lungs, and bones, and less com-
monly to the liver, spleen, brain, and adrenal glands. We present a 49-year-old man who received abdom-
inal ultrasound and magnetic resonance imaging for a health checkup, during which, a necrotic hepatic
tumor was found incidentally. Fluorodeoxyglucose (FDG) positron emission tomography was performed
to search for the primary site of malignancy, and lobulated FDG hypermetabolic lesions in the anterior
mediastinum were found. The diagnosis of thymic carcinoma with liver metastasis was then confirmed
after morphological and immunohistochemical studies of hepatic and mediastinal biopsy specimens. 
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pathology, whole body 18F-fluorodeoxyglucose
positron emission tomography (FDG-PET) was
arranged. It revealed two lobulated, contiguous
mass lesions with FDG hypermetabolism in the
left anterior mediastinum, and a focal FDG hyper-
metabolic spot at the aortopulmonary window
(Figure 1). A round focal area of FDG hyper-
metabolism with a small central cold area in 
segment VIII of the liver was noted. Computed
tomography-guided biopsy of the mediastinal
tumors was performed and a primary thymic car-
cinoma was confirmed by pathology. The hepatic
and mediastinal specimens were reviewed and
immunohistochemical staining showed similar
morphological and immunohistochemical pro-
files between these two specimens (Figure 2; 
see discussion for details). Thus, the diagnosis of
thymic carcinoma with solitary hepatic metastasis
was established.
Discussion
Among those with cancer of unknown primary
(CUP) origin, patients with mainly liver metas-
tases are the most frequent subgroup, which ac-
counts for approximately 25% of all CUP cases.
Moderately to poorly differentiated adenocarci-
noma and undifferentiated types are the most
common histology. The diagnostic evaluation of
patients with CUP includes serum tumor mark-
ers, imaging studies, endoscopy, and pathology.1
Conventional imaging studies such as plain films,
computed tomography and MRI are all regional
studies. In contrast, FDG-PET may be a valuable
diagnostic modality for whole body survey, in
one scan, of the primary site of CUP and other
metastatic sites if conventional imaging studies
are unsuccessful. In 37.8–53% of patients with
CUP, the primary tumors can be localized by
FDG-PET.2–4 Among the primary tumors detected
by FDG-PET, lung cancer is the most common
entity. Other frequently seen primary sites include
head and neck, gastrointestinal tract, pancreas,
breast, kidney, thyroid, uterus, and skin.2–5 How-
ever, to the authors’ knowledge, thymic carcinoma
has not been documented as the primary tumor
for hepatic metastasis detected by FDG-PET.
Immunohistochemical studies can sometimes
be helpful in the identification of tumor origin in
patients with metastatic carcinoma of an unknown
primary site, especially if the metastases are of
poorly differentiated histology by light micros-
copy.1 In the present case, the tumor cells of the
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Figure 1. Whole-body 18F-FDG-PET images reveal intense FDG uptake in the left anterior mediastinum (M), aorto-
pulmonary window lymph node (AP) and liver (L). FDG-PET = fluorodeoxyglucose positron emission tomography.
liver and mediastinum had the same cellular mor-
phology, which was characterized by two cell types.
The first type of tumor cells in the liver comprised
large, polygonal to round cells with a large nu-
cleus, occasional nucleolus, and slightly baso-
philic cytoplasm. The second type of tumor cells
in the thymus comprised large, round or spindle
cells with a hyperchromatic nucleus, scanty baso-
philic cytoplasm, and absence of a nucleolus.
These tumor cells were devoid of clear cells, kera-
tinization, intercellular bridges, and glandular, neu-
roendocrine and/or sarcomatoid differentiation.
The immunohistochemical stains for these un-
differentiated carcinomatous cells demonstrated
immunoreactivity for high-molecular-weight cyto-
keratin and CD5, but were negative for cytokeratin
(CK)-7, CK20, synaptophysin, chromogranin A,
and Hep-Par-1 (hepatocyte-paraffin-1). This was
diagnostic of a thymus-originating undifferenti-
ated carcinoma, probably an anaplastic-type squa-
mous cell carcinoma with liver metastasis, rather
than an undifferentiated hepatocellular carcinoma
with intrathoracic dissemination or double pri-
mary malignancies in the liver and mediastinum.
Thymic carcinoma is a heterogeneous group
of malignancies in the anterior mediastinum.
They are rare, invasive and aggressive tumors that
arise from the thymic epithelium. Most sympto-
matic patients present with chest pain, cough,
dyspnea, and superior vena cava syndrome, while
asymptomatic patients account for 22–31.4% of
thymic carcinoma.6–8
FDG-PET of thymus carcinoma with liver metastasis
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Mediastinal tumor, H&E, 200×.
Mediastinal tumor, peroxidase-antiperoxidase,
CD5(+), 200×.
Hepatic tumor, peroxidase-antiperoxidase,
CD5(+), 200×.
Hepatic tumor, H&E, 200×.
Figure 2. Pathological features of specimens of the: (A) anterior mediastinum and (B) hepatic tumors demonstrate sim-
ilar histological morphology as described in the text. (C, D) The key immunohistochemical stains for CD5 were all posi-
tive. Combined with other immunohistochemical stains for tumor histogenesis, it was concluded that the tumor was a
primary undifferentiated carcinoma of the thymus with metastasis of the liver. H&E = hematoxylin & eosin.
It was noted by Suster and Rosai in 19916
that the histological grading is the most im-
portant prognostic factor for thymic carcinoma.
Low-grade histology (well-differentiated squa-
mous carcinoma, mucoepidermoid carcinoma, or
basaloid carcinoma) tends to have a relatively fa-
vorable course, and is less likely to recur locally or
metastasize. High-grade histology (lymphoepithe-
lioma-like carcinoma, small-cell/neuroendocrine
carcinoma, clear-cell carcinoma, sarcomatoid car-
cinoma, or anaplastic/undifferentiated carcinoma)
is more aggressive, with frequent recurrence and
metastasis. Adjacent structures such as the lung,
pleura, pericardium, great vessels, phrenic nerve,
heart, chest wall, and diaphragm are the common
sites of locoregional invasion.9,10 Sites of metas-
tasis include lymph nodes, lung, bones, liver,
spleen, brain and adrenal glands.6,8–10 Among the
metastatic sites, the liver is relatively uncommon,
ranging from 12.5% to 33.3% of all metastatic
cases.6,8,9 The pathology of the mediastinal tumor
in our case was high-grade histology (poorly dif-
ferentiated carcinoma). In addition to nearby
aortopulmonary lymph node metastasis, it also
metastasized to the liver, a relatively uncommon
site.
Increased FDG uptake in the thymus may rep-
resent normal physiological uptake, as well as a
variety of benign or malignant diseases such as
thymic hyperplasia, lymphomatous infiltration,
primary thymic neoplasm, or metastatic disease.11
It has been proposed that FDG-PET is useful in
the differential diagnosis of primary thymic neo-
plasms, including thymoma and thymic carci-
noma.11–13 The maximum standardized uptake
value (SUV) of thymic carcinoma is significantly
higher than that of high-risk (invasive) thymoma,
which is in turn significantly higher than that of
low-risk (noninvasive) thymoma. Using an SUV
of 5.0 as a cutoff, the sensitivity, specificity and
accuracy for the differentiation between thymic
carcinoma and thymoma is 84.6%, 92.3% and
88.5%, respectively.12 In our case, the SUVs of the
mediastinal masses were between 8.4 and 8.8,
which was suggestive of thymic carcinoma.
In thymic carcinoma, a small proportion (less
than one third) of tumors is found incidentally in
patients who have not complained of any symp-
toms. Local recurrence and distant metastases are
not uncommon for thymic carcinoma but solitary
distant metastasis to the liver is rare. In this report,
we presented an unusual case of an asymptomatic
patient with solitary liver metastasis, in whom a
hepatic tumor was observed by ultrasound during
a health checkup, and the primary site of thymic
carcinoma was found later by FDG-PET.
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